查询: 取消
免责声明:证券数据为本网搜集归纳,尽量保证及时准确,入市投资请以上市公司公布的正式公告为准。本网证券行情存在延时,交易请以交易所即时行情价格为准。所有数据仅供参考,据此入市风险自担。
毕得医药(688073)研究和试验发展
上涨家数:19下跌家数:11平均涨幅:+1.28%
更新时间:2025-12-12 15:00
名称最新价(元)市盈率(倍)涨跌幅
益诺思48.3033306.81+12.06%
昭衍新药34.35114.44+9.99%
美迪西59.89-34.70+5.87%
奥浦迈53.35140.42+4.69%
阳光诺和72.1660.76+3.81%
康龙化成29.9135.17+2.96%
泰格医药50.2870.72+2.22%
诺思格58.3137.20+1.94%
普蕊斯47.2330.70+1.88%
南模生物40.7665.58+1.62%
百诚医药54.00-31.33+1.50%
药石科技38.8645.17+1.44%
博济医药9.45491.73+1.39%
泓博医药30.70117.12+1.12%
药康生物15.8353.42+0.96%
毕得医药67.4940.01+0.73%
药明康德94.0518.72+0.70%
泰坦科技21.68248.38+0.32%
近岸蛋白39.35-42.47+0.08%
睿智医药9.82-31.010.00%
万邦医药40.1165.47-0.02%
百普赛斯54.1752.42-0.07%
百花医药10.4179.74-0.29%
成都先导24.1484.76-0.29%
阿拉丁12.9351.23-0.39%
皓元医药73.5052.86-0.46%
中源协和26.44165.53-0.60%
义翘神州67.1461.50-1.10%
和元生物6.77-14.94-1.17%
诺唯赞20.29-272.31-1.50%
C百奥58.23104.12-9.69%

转至毕得医药(688073)行情首页

中财网版权所有(C) HTTP://WWW.CFi.CN